2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Gonçalves VSS et al. | Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs. | 2016 | Int J Pharm | pmid:27702697 |
| Yu X et al. | Melanoma therapy with transdermal mitoxantrone cubic phases. | 2016 | Drug Deliv | pmid:25835224 |
| Ikeda I et al. | Resistant Maltodextrin Decreases Micellar Solubility of Lipids and Diffusion of Bile Salt Micelles and Suppresses Incorporation of Micellar Fatty Acids into Caco-2 Cells. | 2016 | J. Nutr. Sci. Vitaminol. | pmid:27928121 |
| Shen J et al. | Preparation and evaluation of a self-nanoemulsifying drug delivery system loaded with Akebia saponin D-phospholipid complex. | 2016 | Int J Nanomedicine | pmid:27713630 |
| Freag MS et al. | Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies. | 2016 | Int J Nanomedicine | pmid:27703348 |
| Li JC et al. | Self-Assembled Cubic Liquid Crystalline Nanoparticles for Transdermal Delivery of Paeonol. | 2015 | Med. Sci. Monit. | pmid:26517086 |
| Elnaggar YS et al. | Novel piperine-loaded Tween-integrated monoolein cubosomes as brain-targeted oral nanomedicine in Alzheimer's disease: pharmaceutical, biological, and toxicological studies. | 2015 | Int J Nanomedicine | pmid:26346130 |
| Carneiro C et al. | DODAB:monoolein liposomes containing Candida albicans cell wall surface proteins: a novel adjuvant and delivery system. | 2015 | Eur J Pharm Biopharm | pmid:25499956 |
| Peng X et al. | Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin. | 2015 | Drug Des Devel Ther | pmid:26345516 |
| Liang YL et al. | Uptake of the butyrate receptors, GPR41 and GPR43, in lipidic bicontinuous cubic phases suitable for in meso crystallization. | 2015 | J Colloid Interface Sci | pmid:25490566 |